Cargando…

Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence

OBJECTIVES: Alterations in the intestinal microbiota are linked with a wide range of autoimmune and inflammatory conditions, including inflammatory bowel diseases (IBD), where pathobionts penetrate the intestinal barrier and promote inflammatory reactions. In patients with IBD, the ability of intest...

Descripción completa

Detalles Bibliográficos
Autores principales: Spalinger, Marianne Rebecca, Shawki, Ali, Chatterjee, Pritha, Canale, Vinicius, Santos, Alina, Sayoc-Becerra, Anica, Scharl, Michael, Tremblay, Michel L, Borneman, James, McCole, Declan F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666829/
https://www.ncbi.nlm.nih.gov/pubmed/33563644
http://dx.doi.org/10.1136/gutjnl-2020-323636
_version_ 1784614278505955328
author Spalinger, Marianne Rebecca
Shawki, Ali
Chatterjee, Pritha
Canale, Vinicius
Santos, Alina
Sayoc-Becerra, Anica
Scharl, Michael
Tremblay, Michel L
Borneman, James
McCole, Declan F
author_facet Spalinger, Marianne Rebecca
Shawki, Ali
Chatterjee, Pritha
Canale, Vinicius
Santos, Alina
Sayoc-Becerra, Anica
Scharl, Michael
Tremblay, Michel L
Borneman, James
McCole, Declan F
author_sort Spalinger, Marianne Rebecca
collection PubMed
description OBJECTIVES: Alterations in the intestinal microbiota are linked with a wide range of autoimmune and inflammatory conditions, including inflammatory bowel diseases (IBD), where pathobionts penetrate the intestinal barrier and promote inflammatory reactions. In patients with IBD, the ability of intestinal macrophages to efficiently clear invading pathogens is compromised resulting in increased bacterial translocation and excessive immune reactions. Here, we investigated how an IBD-associated loss-of-function variant in the protein tyrosine phosphatase non-receptor type 2 (PTPN2) gene, or loss of PTPN2 expression affected the ability of macrophages to respond to invading bacteria. DESIGN: IBD patient-derived macrophages with wild-type (WT) PTPN2 or carrying the IBD-associated PTPN2 SNP, peritoneal macrophages from WT and constitutive PTPN2-knockout mice, as well as mice specifically lacking PTPN2 in macrophages were infected with non-invasive K12 Escherichia coli, the human adherent-invasive E. coli (AIEC) LF82, or a novel mouse AIEC (mAIEC) strain. RESULTS: Loss of PTPN2 severely compromises the ability of macrophages to clear invading bacteria. Specifically, loss of functional PTPN2 promoted pathobiont invasion/uptake into macrophages and intracellular survival/proliferation by three distinct mechanisms: Increased bacterial uptake was mediated by enhanced expression of carcinoembryonic antigen cellular adhesion molecule (CEACAM)1 and CEACAM6 in PTPN2-deficient cells, while reduced bacterial clearance resulted from defects in autophagy coupled with compromised lysosomal acidification. In vivo, mice lacking PTPN2 in macrophages were more susceptible to mAIEC infection and mAIEC-induced disease. CONCLUSIONS: Our findings reveal a tripartite regulatory mechanism by which PTPN2 preserves macrophage antibacterial function, thus crucially contributing to host defence against invading bacteria.
format Online
Article
Text
id pubmed-8666829
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-86668292021-12-28 Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence Spalinger, Marianne Rebecca Shawki, Ali Chatterjee, Pritha Canale, Vinicius Santos, Alina Sayoc-Becerra, Anica Scharl, Michael Tremblay, Michel L Borneman, James McCole, Declan F Gut Gut Microbiota OBJECTIVES: Alterations in the intestinal microbiota are linked with a wide range of autoimmune and inflammatory conditions, including inflammatory bowel diseases (IBD), where pathobionts penetrate the intestinal barrier and promote inflammatory reactions. In patients with IBD, the ability of intestinal macrophages to efficiently clear invading pathogens is compromised resulting in increased bacterial translocation and excessive immune reactions. Here, we investigated how an IBD-associated loss-of-function variant in the protein tyrosine phosphatase non-receptor type 2 (PTPN2) gene, or loss of PTPN2 expression affected the ability of macrophages to respond to invading bacteria. DESIGN: IBD patient-derived macrophages with wild-type (WT) PTPN2 or carrying the IBD-associated PTPN2 SNP, peritoneal macrophages from WT and constitutive PTPN2-knockout mice, as well as mice specifically lacking PTPN2 in macrophages were infected with non-invasive K12 Escherichia coli, the human adherent-invasive E. coli (AIEC) LF82, or a novel mouse AIEC (mAIEC) strain. RESULTS: Loss of PTPN2 severely compromises the ability of macrophages to clear invading bacteria. Specifically, loss of functional PTPN2 promoted pathobiont invasion/uptake into macrophages and intracellular survival/proliferation by three distinct mechanisms: Increased bacterial uptake was mediated by enhanced expression of carcinoembryonic antigen cellular adhesion molecule (CEACAM)1 and CEACAM6 in PTPN2-deficient cells, while reduced bacterial clearance resulted from defects in autophagy coupled with compromised lysosomal acidification. In vivo, mice lacking PTPN2 in macrophages were more susceptible to mAIEC infection and mAIEC-induced disease. CONCLUSIONS: Our findings reveal a tripartite regulatory mechanism by which PTPN2 preserves macrophage antibacterial function, thus crucially contributing to host defence against invading bacteria. BMJ Publishing Group 2022-01 2021-02-09 /pmc/articles/PMC8666829/ /pubmed/33563644 http://dx.doi.org/10.1136/gutjnl-2020-323636 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Gut Microbiota
Spalinger, Marianne Rebecca
Shawki, Ali
Chatterjee, Pritha
Canale, Vinicius
Santos, Alina
Sayoc-Becerra, Anica
Scharl, Michael
Tremblay, Michel L
Borneman, James
McCole, Declan F
Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence
title Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence
title_full Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence
title_fullStr Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence
title_full_unstemmed Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence
title_short Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence
title_sort autoimmune susceptibility gene ptpn2 is required for clearance of adherent-invasive escherichia coli by integrating bacterial uptake and lysosomal defence
topic Gut Microbiota
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666829/
https://www.ncbi.nlm.nih.gov/pubmed/33563644
http://dx.doi.org/10.1136/gutjnl-2020-323636
work_keys_str_mv AT spalingermariannerebecca autoimmunesusceptibilitygeneptpn2isrequiredforclearanceofadherentinvasiveescherichiacolibyintegratingbacterialuptakeandlysosomaldefence
AT shawkiali autoimmunesusceptibilitygeneptpn2isrequiredforclearanceofadherentinvasiveescherichiacolibyintegratingbacterialuptakeandlysosomaldefence
AT chatterjeepritha autoimmunesusceptibilitygeneptpn2isrequiredforclearanceofadherentinvasiveescherichiacolibyintegratingbacterialuptakeandlysosomaldefence
AT canalevinicius autoimmunesusceptibilitygeneptpn2isrequiredforclearanceofadherentinvasiveescherichiacolibyintegratingbacterialuptakeandlysosomaldefence
AT santosalina autoimmunesusceptibilitygeneptpn2isrequiredforclearanceofadherentinvasiveescherichiacolibyintegratingbacterialuptakeandlysosomaldefence
AT sayocbecerraanica autoimmunesusceptibilitygeneptpn2isrequiredforclearanceofadherentinvasiveescherichiacolibyintegratingbacterialuptakeandlysosomaldefence
AT scharlmichael autoimmunesusceptibilitygeneptpn2isrequiredforclearanceofadherentinvasiveescherichiacolibyintegratingbacterialuptakeandlysosomaldefence
AT tremblaymichell autoimmunesusceptibilitygeneptpn2isrequiredforclearanceofadherentinvasiveescherichiacolibyintegratingbacterialuptakeandlysosomaldefence
AT bornemanjames autoimmunesusceptibilitygeneptpn2isrequiredforclearanceofadherentinvasiveescherichiacolibyintegratingbacterialuptakeandlysosomaldefence
AT mccoledeclanf autoimmunesusceptibilitygeneptpn2isrequiredforclearanceofadherentinvasiveescherichiacolibyintegratingbacterialuptakeandlysosomaldefence